Perspectives on the Genomics of HSP Beyond Mendelian Inheritance

被引:21
作者
Bis-Brewer, Dana M. [1 ,2 ]
Zuchner, Stephan [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA
来源
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
关键词
heredit spastic paraplegia; genomics; risk allele; Mendelian; non-Mendelian inheritance; HEREDITARY SPASTIC PARAPLEGIA; AMYOTROPHIC-LATERAL-SCLEROSIS; RARE VARIANT ASSOCIATION; UNIPARENTAL DISOMY; FRONTOTEMPORAL DEMENTIA; EXON DELETIONS; GENETIC BURDEN; MUTATIONS; DISEASE; PHENOTYPES;
D O I
10.3389/fneur.2018.00958
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hereditary Spastic Paraplegia is an extraordinarily heterogeneous disease caused by over 50 Mendelian genes. Recent applications of next-generation sequencing, large scale data analysis, and data sharing/matchmaking, have discovered a quickly expanding set of additional HSP genes. Since most recently discovered HSP genes are rare causes of the disease, there is a growing concern of a persisting diagnostic gap, estimated at 30-40%, and even higher for sporadic cases. This missing heritability may not be fully closed by classic Mendelian mutations in protein coding genes. Here we show strategies and published examples of broadening areas of attention for Mendelian and non-Mendelian causes of HSP. We suggest a more inclusive perspective on the potential final architecture of HSP genomics. Efforts to narrow the heritability gap will ultimately lead to more precise and comprehensive genetic diagnoses, which is the starting point for emerging, highly specific gene therapies.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Melanoma genomics - will we go beyond BRAF in clinics?
    Mirek, Justyna
    Bal, Wieslaw
    Olbryt, Magdalena
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
  • [42] BEYOND THE HELIX: ETHICAL, LEGAL, AND SOCIAL IMPLICATIONS IN GENOMICS
    Hammer, Marilyn J.
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (01) : 93 - 106
  • [43] Developments beyond blood group serology in the genomics era
    Hyland, Catherine A.
    Roulis, Eileen V.
    Schoeman, Elizna M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (06) : 897 - 911
  • [44] Current advances in chickpea genomics: applications and future perspectives
    Uday Chand Jha
    Plant Cell Reports, 2018, 37 : 947 - 965
  • [45] Hereditary spastic paraplegia: clinical genomics and pharmacogenetic perspectives
    Contino, Gianmarco
    Novelli, Giuseppe
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (14) : 1849 - 1856
  • [46] Advances in European sea bass genomics and future perspectives
    Louro, Bruno
    Power, Deborah M.
    Canario, Adelino V. M.
    MARINE GENOMICS, 2014, 18 : 71 - 75
  • [47] Current advances in chickpea genomics: applications and future perspectives
    Jha, Uday Chand
    PLANT CELL REPORTS, 2018, 37 (07) : 947 - 965
  • [48] Genetics and Genomics of Breast Cancer: update and translational perspectives
    Biancolella, Michela
    Testa, Barbara
    Salehi, Leila Baghernajad
    D'Apice, Maria Rosaria
    Novelli, Giuseppe
    SEMINARS IN CANCER BIOLOGY, 2021, 72 : 27 - 35
  • [49] Spinal Cord Involvement in Pediatric-Onset Metabolic Disorders With Mendelian and Mitochondrial Inheritance
    Tabarki, Brahim
    Hakami, Wejdan
    Alkhuraish, Nader
    Tlili-Graies, Kalthoum
    Alfadhel, Majid
    FRONTIERS IN PEDIATRICS, 2021, 8
  • [50] Genomics and medicine: an anticipation. From Boolean Mendelian genetics to multifactorial molecular medicine
    Kaplan, JC
    Junien, C
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 2000, 323 (12): : 1167 - 1174